GBIO
GBIO
NASDAQ · Biotechnology

Generation Bio Co

$5.34
-0.40 (-6.97%)
As of Mar 28, 1:46 AM ET ·
Financial Highlights (FY 2026)
Revenue
20.12M
Net Income
-133,172,516
Gross Margin
Profit Margin
-661.9%
Rev Growth
+692.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 65.1% 65.1% 65.1%
Operating Margin -715.8% -17.0% -17.5% -18.1%
Profit Margin -661.9% -17.1% -22.3% -16.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 20.12M 21.13M 21.81M 22.76M
Gross Profit 13.75M 14.19M 14.81M
Operating Income -144,017,779 -3,596,731 -3,814,769 -4,129,002
Net Income -133,172,516 -3,613,419 -4,862,244 -3,816,324
Gross Margin 65.1% 65.1% 65.1%
Operating Margin -715.8% -17.0% -17.5% -18.1%
Profit Margin -661.9% -17.1% -22.3% -16.8%
Rev Growth +692.3% -1.2% +1.1% +19.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 9.32M 8.36M 7.86M
Total Equity 12.94M 13.19M 12.87M
D/E Ratio 0.72 0.63 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -139,029,659 -5,916,348 -5,182,437 -6,404,056
Free Cash Flow -5,168,786 -3,508,220 -3,760,769